Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation.
Teraoka
S
S
Department of Surgery, Tokyo Women's Medical College, Japan.
Takahashi
K
K
Toma
H
H
Sanaka
T
T
Yamaguchi
Y
Y
Tanabe
K
K
Sato
H
H
Kawaguchi
H
H
Oba
S
S
Nakajima
I
I
D000179:Acrylates / Q000627:therapeutic use*; D002908:Chronic Disease; D011464:Epoprostenol / Q000627:therapeutic use* / Q000031:analogs & derivatives; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation; D008689:Methacrylates / Q000627:therapeutic use*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D013988:Ticlopidine / Q000627:therapeutic use; D013997:Time Factors; D014652:Vascular Diseases / Q000188:drug therapy*
D000179:Acrylates; D008689:Methacrylates; D011464:Epoprostenol; D013930:Thromboxane-A Synthase; C034364:ozagrel; C035847:ataprost; D013988:Ticlopidine